Product Code: RP-ID-10294002 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Chemicals |
Report ID: 10294002
Market Overview:
Superdisntegrants Market, By Product (Crospovidone, Croscarmellose sodium, Ion Exchange Resin, Sodium Starch Glycolate, Others), by Dosage Form, by Geography (NA, EU, APAC, and RoW) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025
REPORT HIGHLIGHT
The superdisintegrants market was valued at USD 380.2 million by 2017, growing with 8.1% CAGR during the forecast period, 2018-2025
Market Dynamics
In contemporary oral medicines, disintegrants are added for aiding a quick dilution of the tablet in an aqueous environment and complementing a spontaneous release of the drug substance. A new genre of disintegrants has emerged in the market that is known as superdisintegrants. Natural products are biodegradable, chemically inert, and widely available. The good thing about it is you can customize it in several ways to dispense a system of drug delivery. Mucilages and natural gums are among the two widely used pharmaceutical superdisintegrants.
In modern oral medicines, these products are used in the form of emulsifiers, stabilizers, gelling agent, granulating agent, thickener, binder, and film former in the pharmaceutical industry. Over the years the demand for superdisintegrants made from natural sources has sky-rocketed because they are readily available and economically priced. Moreover, they are non-irritant and deliver soothing action.
Further, the natural product will receive a boost by virtue of being eco-friendly, and adaptable to several chemical modifications which make them compatible with different kinds of medicines. However, concerns over safety and quality are going to impede the market growth of superdisintegrants to large extent in the forecasted period.
Product Takeaway
The industry is segmented into natural, synthetic, and others. The synthetic products are further categorized into cross-linked polyvinylpyrrolidone (crospovidone), modified cellulose, calcium silicates, and ion exchange resins. In 2017, Crospovidone had the biggest revenue share. One of the reasons for such dominance in the market could be attributed to its higher crosslinking density. As a result, it swells rapidly in water without taking the form of a gel. It has a unique particle morphology featuring highly compressible materials.
Croscarmellose sodium is an FDA approved superdisintegrants that works on the principles of cross-linking paving the way for a much-improved bioavailability through superior drug dissolution. The use of this substance has been deemed safe by FDA when used in normal quantities.
Dosage Form Insights
The industry, in 2017, was dominated by solid dosage forms i.e. capsules and tablets. Superdisintegrants are one of the most important excipients of capsule and tablet formulation because they are capable of inducing breakups the moment it comes into contact with aqueous fluid. Capsules and tablets have quick dissolving dosage form duly recognized by FDA. The doses are listed in the catalog of approved drug products along with therapeutic equivalence evaluations that would be boosting the segment’s growth. The number of disintegrates having usage in multifunctional tablet and capsule formulation is inclusive of starch, crospovidone, cellulose, and others. Mouth dissolving films segment will experience the highest growth during the forecasted period. Ability to rapidly disintegrate and dissolve in the oral cavity, accurate dosing, quick action, better patient compliance for the pediatric population are the factors propelling the growth of the segment.
Regional Takeaway
North America is the dominant region owing to the surging demand for generic drugs, better innovation in the manufacturing of this chemical product. It is anticipated that by virtue of increased outsourcing of excipients the Asia Pacific region will grow at the fastest CAGR along with manufacturing of the latest superdisintegrants, and incorporation of novel technologies.
The emergence of pharmaceutical giants in the region with humungous production capabilities and high consumption of excipients provides a befitting explanation for the large share of this region. Moreover, the ever-increasing demand for superior pharmaceutical products and generics will provide the necessary impetus for sustainable growth in the region.
Key Vendor Takeaways
Currently, the industry is fragmented in itself with the presence of numerous key vendors. The companies that dominate the global market are Ashland Global Holdings, Inc., FMC Corporation, DFE Pharma, Nippon Soda Co., Ltd., Dow Pharma Solutions, and BASFStrategic undertakings of these companies to increase their revenue share over the future period emphasizes on mergers, acquisition, and regional expansions.
The market size and forecast for each segment and sub-segments has been considered as below:
Historical Year – 2014 & 2016
Base Year – 2017
Estimated Year – 2018
Projected Year – 2025
TARGET AUDIENCE
Traders, Distributors, and Suppliers
Manufacturers
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
MARKET, BY PRODUCT
Crospovidone
Croscarmellose sodium
Ion Exchange Resin
Sodium Starch Glycolate
Others
MARKET, BY DOSAGE FORM
Solid Dosage Form
Mouth-dissolving Films
MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America
Related Reports
Proof of Quality & Reliability
